Outset Medical, Inc. (NASDAQ: OM) is a Healthcare company (Medical - Devices) with a market capitalization of $60M. The Maz Rating grades it against the other companies in its sector.
Outset Medical, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $3.16, Outset Medical, Inc. trades at 0.5x sales and 0.7x book value. Over the last twelve months it generated about $123M of revenue and a net loss of $73M. It runs a gross margin of 42.0%, an operating margin of -51.2% and a net margin of -58.3%. It shows return on equity of -68.0%, return on invested capital of -33.2% and a free cash flow yield of -72.0%. On the balance sheet: a debt-to-equity ratio of 1.26 and a current ratio of 4.86. Over the past 52 weeks the share price ranged from $2.84 to $6.49, with a beta of 1.92.
Outset Medical, Inc. does not currently pay a dividend.
11 Wall Street analyst ratings cover the stock: 7 Buy, 3 Hold and 1 Sell, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Outset Medical, Inc. is a medical technology firm that specializes in developing hemodialysis systems. The company's primary product is the Tablo Hemodialysis System, a compact console designed to deliver dialysis treatment in various environments, including hospitals and patients' homes. This innovative system boasts integrated water purification, on-demand production of dialysate, and advanced software complete with connectivity features. Founded in 2003, the company initially operated under the name Home Dialysis Plus, Ltd. before rebranding to Outset Medical, Inc. in January 2015. Its corporate headquarters are located in San Jose, California.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
No. As of September 2026, Outset Medical, Inc. (OM) is classified as NOT HALAL by Maz Vantage: it fails every published Shariah screening standard it could be measured against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 138.5% / 30% · (Cash+Inv) / Mkt Cap (36m) 192.3% / 30% · Interest income / Revenue 3.69% / 5% | Fail |
| S&P Global | Debt / Mkt Cap (36m) 138.5% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 192.3% / 33% · Receivables / Mkt Cap (36m) 42.8% / 49% · Interest income / Revenue 3.69% / 5% | Fail |
| Dow Jones | Debt / Mkt Cap (24m) 138.5% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 192.3% / 33.33% · Receivables / Mkt Cap (24m) 42.8% / 33.33% · Interest income / Revenue 3.69% / 5% | Fail |
| MSCI | Debt / Avg Assets (4Q) 39.4% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 61.8% / 33.33% · Receivables / Avg Assets (4Q) 11.5% / 33.33% · Interest income / Revenue 3.69% / 5% | Fail |
| FTSE | Debt / Total Assets 42.7% / 33.33% · (Cash+ST Inv) / Total Assets 59.3% / 33.33% · (Cash+Recv) / Total Assets 72.5% / 33.33% · Interest income / Revenue 3.69% / 5% | Fail |
No. As of September 2026, Outset Medical, Inc. (OM) is classified as NOT HALAL by Maz Vantage: it fails every published Shariah screening standard it could be measured against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
No. Outset Medical, Inc. is over the AAOIFI limit on Debt / Mkt Cap (36m) and (Cash+Inv) / Mkt Cap (36m).
About 3.69% of each dividend: Outset Medical, Inc.'s interest income as a share of its revenue. Give that share to charity; the dividend purification calculator works it out per holding.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated September 30, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, halal healthcare stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.